期刊文献+

抗病毒药物缬更昔洛韦的合成研究 被引量:5

Synthesis of anti-viral agent valganciclovir
下载PDF
导出
摘要 目的探索更简便的合成缬更昔洛韦的工艺路线,为进一步研究开发提供基础。方法以更昔洛韦为原料,经过酯化、还原两步反应得到目标物缬更昔洛韦。结果实验路线简便,总收率达到20%。结论本文探索了简便的缬更昔洛韦合成工艺,确立了比较合理的酯化条件,改进了氢化脱保护基条件,为将该工艺用于中试放大提供了依据。 Objective To explore a simple synthetic route of valganciclovir for its further development. Method Valganciclovir was synthesized through esterification and hydrogenation, using ganciclovir as starting material. Results The total yield was above 20%. Conclusions It is feasible to synthesize valganciclovir using ganciclovir as starting material through esterification and with the modified deprotection method by (hydrogenation). The proposed method could be used for large-scale preparation of valganciclovir.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2005年第6期336-337,353,共3页 Chinese Journal of Antibiotics
关键词 抗病毒药物 更昔洛韦 缬更昔洛韦 合成 Anti-viral agent Ganciclovir Valganciclovir Synthesis
  • 相关文献

参考文献4

  • 1Pescovitz MD. Formulary considerations for drugs used to prevent cytomegalovirus disease [J]. Am J Health Syst Pharm,2003,60(Suppl 8) :S17 被引量:1
  • 2Segarra-Newnham M, Salazar M I. Valganciclovir: A new oral alternative for cytomegalovirus retinitis in human immunodeficiency virus-seropositive individuals [J]. Pharmacot heropy, 2002,22 (9): 1124 被引量:1
  • 3John J N, Scott W W, Hans M. 2-(2-amino-1,6- dihydro-6-oxo-purin-9-yl ) methoxy-1, 3-propanediol derivative[P]. EP: 0694547,1996-01-31 被引量:1
  • 4E.C.霍宁..有机合成 第3集[M].北京:科学出版社,1981:576.

同被引文献32

  • 1侯舒,王亚亭.抗人巨细胞病毒药物及其治疗研究进展[J].国外医学(儿科学分册),2004,31(5):234-237. 被引量:6
  • 2HUMBERTO B ARZENO, CUPERTINO, ERIC R HUMPHREYS, et al. a 2-(2-amino-1, 6-dihydro-6-oxopurin-9-yl ) methoxy-1, 3-propanediol derivative: US, 5756736 [ P]. 1998-05-26. 被引量:1
  • 3HUMBERTO B ARZENO, CUPERTINO, ERIC R HUMPHREYS, et al. Process for preparing a 2-(2-amino-1, 6-dihydro-6- oxo- purin-9- yl ) methoxy-1, 3-propanediol derivative : US, 5840890[ P]. 1998-11-24. 被引量:1
  • 4HUMBERTO B ARZENO, CUPERTINO, ERIC R HUMPHREYS, et al. Process for preparing a 2-(2-amino- 1, 6-dihydro-6-oxo-purin-9-yl ) methoxy-1, 3-propanediol derivative : US, 6103901 [ P ]. 2000-08-15. 被引量:1
  • 5CHARLES A DVORAK, DOUGLAS L WREN, PALO ALTO, et al. Process for preparing a 2-(2-amino-1, 6-dihydro-6- oxo-purin-9-yl ) methoxy- 1, 3-propanediol derivative : US, 6040446 [ P]. 2000-03-21. 被引量:1
  • 6JOHN J NESTOR JR, LOUISVILLE KY, et al. 2-(2- Amino-1, 6-dihydro-6-oxo-purin-9-yl ) methoxy-1, 3- propanediol derivative: US ,5840891 [ P]. 1998-11-24. 被引量:1
  • 7战寒秋.缬更昔洛韦.国外医学:药学分册,2002,29(3):181-181. 被引量:1
  • 8王欣伊.更昔洛韦市场-逆势增长前景乐观[ED/OL].http://www.pharmNet.com.cn.2007-03-06. 被引量:1
  • 9ARZENO H B, BEARD C C, FISHER L E, et al. Process for preparing purine derives : WO, 9727194 [ P]. 1997-01-18. 被引量:1
  • 10HUMBERTO B ARZENO. Process for preparing a 2-(2- amino-1,6-dihydro-6-oxo-purin-9-yl ) methoxy-1, 3-propanediol valinate : US, 5700936 [ P ] . 1997-12-23. 被引量:1

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部